Prognosis and Improved Outcomes in Major Depression: A Review
Overview
Affiliations
(Reprinted from . 2019 Apr 3; 9(1):127. Open access; is licensed under a Creative Commons Attribution 4.0 International License).
Towards an expanded neurocognitive account of ketamine's rapid antidepressant effects.
Dai Y, Harrison B, Davey C, Steward T Int J Neuropsychopharmacol. 2025; 28(2).
PMID: 39921611 PMC: 11879094. DOI: 10.1093/ijnp/pyaf010.
Xiao Y, Dong S, Pan C, Guo H, Tang L, Zhang X Psychoradiology. 2024; 4:kkae025.
PMID: 39659696 PMC: 11629992. DOI: 10.1093/psyrad/kkae025.
Clinical associations with treatment resistance in depression: An electronic health record study.
Coombes B, Sanchez-Ruiz J, Fennessy B, Pazdernik V, Adekkanattu P, Nunez N Psychiatry Res. 2024; 342():116203.
PMID: 39321638 PMC: 11617277. DOI: 10.1016/j.psychres.2024.116203.
Causes and consequences of major depressive disorder: An encompassing Mendelian randomization study.
Pasman J, Bergstedt J, Harder A, Gong T, Xiong Y, Hagg S medRxiv. 2024; .
PMID: 38826420 PMC: 11142270. DOI: 10.1101/2024.05.21.24307678.
Ku W, Min H Healthcare (Basel). 2024; 12(6).
PMID: 38540589 PMC: 11154473. DOI: 10.3390/healthcare12060625.